期刊
ATHEROSCLEROSIS
卷 199, 期 2, 页码 237-247出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2008.03.006
关键词
endothelin-1; vascular smooth muscle cell; cell signalling; atherosclerosis
资金
- National Health & Medical Research Council of Australia
- National Heart Foundation of Australia and the Diabetes Australia Research Trust
- National Health & Medical Research Council of Australia Scholarship and Monash University and the Baker Heart Research Institute
- Eli Lilly Endocrinology Research Awards and GlaxoSmithKline Kline student Support awards
Atherosclerosis is the primary ischaemic Vascular condition Underlying a majority of cardiovascular disease related deaths. Endothelin-1 is a vasoactive peptide agent upregulated in atherosclerosis and in conjunction with its G protein-coupled receptors exerts diverse actions oil all cells of the vasculature in particular vascular smooth muscle cells (VSMC). The effects of endothelin-1 include cell proliferation, migration and contraction, and the induction of extracellular matrix components and growth factors. VSMC as the major component of the neointima in atherosclerotic plaques accordingly play a key role in atherogenesis. In this review we examine classic and novel signalling pathways activated by endothelin-1 ill VSMC (including phospholipase C, adenylate cyclase, Rho kinase, transactivation of receptor tyrosine kinases, mitogen activated protein kinase cascades and beta-arrestin) and their likely impact on the development and progression of atherosclerosis. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据